Asfotase alfa

N/A

Report date: 2022/03/23 17:09:35
First In Class

Base Information

Drug NameAsfotase alfa
Drug Alias Nameasfotase alfa阿司福酶α阿福他酶αasfotasum alfaAsfotase alpha +[12] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionAlkaline phosphatase, tissue-nonspecific isozyme replacements
TargetsAlkaline phosphatase, tissue-nonspecific isozyme
Therapy Area/IndicationsHypophosphatasia
Global Approved IndicationsHypophosphatasia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2015/07/03
Country/TerritoryCanadaUnited StatesSaudi Arabia +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAlexion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlexion Europe SasAlexion Pharmaceuticals Inc
Inactive CompaniesOsaka University Graduate School Of Medicine
Active IndicationsHypophosphatasia
Inactive IndicationsN/A

Other Information

ATC CodeA16AB13
Related LinksWikipediaDrugBankKEGG